What other stocks do shareholders of SuperGen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SuperGen investors own include Acorda Therapeutics (ACOR) , AcelRx Pharmaceuticals (ACRX) , ADMA Biologics (ADMA) , Akebia Therapeutics (AKBA) , Caladrius Biosciences (CLBS) , Corbus Pharmaceuticals (CRBP) , DBV Technologies (DBVT) , Gevo (GEVO) , Lexicon Pharmaceuticals (LXRX) and Mallinckrodt (MNK) .

NASDAQ:SUPG

SuperGen (SUPG) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free SUPG Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get SuperGen alerts:

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About SuperGen

Astex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company. The Company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. It is also engaged in the application of fragment-based drug discovery and development of small-molecule therapeutics. Using its fragment-based drug discovery platform, Pyramid, Astex Therapeutics Limited, a wholly owned subsidiary, has built a pipeline of molecularly-targeted drugs for large pharmaceutical partners and internal development that are at various stages of clinical, pre-clinical and early discovery development. In October 2013, Otsuka Holdings Co Ltd announced that its wholly owned subsidiary, Otsuka Pharmaceutical Co., Ltd completed, through its wholly owned indirect subsidiary Autumn Acquisition Corporation, its acquisition of Astex Pharmaceuticals, Inc.

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

SUPG Stock News Headlines

March 20, 2023 | thestreet.com

Zoran Stumbles; SuperGen Soars

March 16, 2023 | thestreet.com

SuperGen Skepticism No Longer Warranted

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

January 21, 2023 | thestreet.com

A Negative for SuperGen, a Plus for Celgene

October 21, 2022 | investing.com

Supreme Engineering Ltd (SUPG)

See More Headlines

Receive SUPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SuperGen and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:SUPG
CUSIP: N/A
CIK: 919722
Web: astx.com
Phone: +1-925-5600100
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

SUPG Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of SuperGen own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SuperGen investors own include Acorda Therapeutics (ACOR), AcelRx Pharmaceuticals (ACRX), ADMA Biologics (ADMA), Akebia Therapeutics (AKBA), Caladrius Biosciences (CLBS), Corbus Pharmaceuticals (CRBP), DBV Technologies (DBVT), Gevo (GEVO), Lexicon Pharmaceuticals (LXRX) and Mallinckrodt (MNK).

This page (NASDAQ:SUPG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SuperGen (SUPG) Stock Price, News & Analysis

About SuperGen

SUPG Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

SUPG Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info